ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Cancer Society, Centers Explore Collaboration On Public Issued, Education, Information Activities

January 25, 1991